OAG
AMGN icon

Orbis Allan Gray’s Amgen AMGN Stock Holding History

Orbis Allan Gray’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-251,860
Closed -$49M – 58
2018
Q4 		$49M Sell
251,860
-11,591
-4% -$2.26M 0.35% 35
2018
Q3 		$54.6M Buy
263,451
+279
+0.1% +$55K 0.31% 37
2018
Q2 		$48.6M Sell
263,172
-120
-0% -$21.2K 0.27% 39
2018
Q1 		$44.9M Sell
263,292
-36,734
-12% -$6.74M 0.26% 42
2017
Q4 		$52.2M Buy
300,026
+39
+0% +$6.9K 0.31% 38
2017
Q3 		$55.9M Buy
299,987
+46,639
+18% +$8.26M 0.35% 40
2017
Q2 		$43.6M Buy
+253,348
New +$41.2M 0.27% 42
2016
Q2 		– Sell
-76,942
Closed -$11.5M – 79
2016
Q1 		$11.5M Buy
+76,942
New +$11.4M 0.09% 63

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Orbis Allan Gray's AMGN Position: Q1 2019 in Review

Orbis Allan Gray sold out of Amgen (AMGN) in Q1 2019, closing a stake of 251,860 shares — an estimated $49M sold.

Orbis Allan Gray first reported a position in AMGN in Q1 2016 and held it in 8 quarters. The position peaked at $55.9M in Q3 2017. 1,886 funds tracked by Wall St. Rank hold AMGN as of Q1 2019.

  • Orbis Allan Gray reported no remaining Amgen position as of Q1 2019 after selling out during the quarter.
  • Orbis Allan Gray sold 251,860 Amgen shares in Q1 2019, an estimated $49M.
  • Orbis Allan Gray first reported a position in Amgen in Q1 2016 and held it in 8 quarters.
  • Orbis Allan Gray's Amgen position peaked at $55.9M in Q3 2017.
  • 1,886 funds tracked by Wall St. Rank held Amgen as of Q1 2019.

Based on Orbis Allan Gray's 13F filing for Q1 2019, filed 15 May 2019.